Literature DB >> 7255507

The treatment of peritonitis by an antiseptic - taurolin.

M K Browne.   

Abstract

An open study was carried out on patients with acute appendicitis to assess the effectiveness of taurolin, a new antiseptic which destroys both bacteria and endotoxin, when used intraperitoneally in cases of purulent peritonitis associated with perforated or gangrenous appendicitis. Seventy-four out of 319 patients received taurolin; the others were treated by operation only or by operation and antibiotics as required. The results suggest that taurolin was effective as monotherapy in peritonitis and endotoxic shock and its use avoids the problems associated with antibiotics.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7255507

Source DB:  PubMed          Journal:  Pharmatherapeutica        ISSN: 0308-051X


  7 in total

1.  AIDS and taurolin.

Authors:  P Bayardelle
Journal:  CMAJ       Date:  1986-03-01       Impact factor: 8.262

2.  Antibacterial effect of taurolidine (2%) on established dental plaque biofilm.

Authors:  Nicole Birgit Arweiler; Thorsten Mathias Auschill; Anton Sculean
Journal:  Clin Oral Investig       Date:  2011-03-01       Impact factor: 3.573

3.  Oral administration of the anti-proliferative substance taurolidine has no impact on dextran sulfate sodium induced colitis-associated carcinogenesis in mice.

Authors:  Ansgar Michael Chromik; Sebastian Huss; Hayssam Osseili; Adrien Daigeler; Sabine Kersting; Dominique Sülberg; Ulrich Mittelkötter; Thomas Herdegen; Waldemar Uhl; Annette M Müller
Journal:  J Carcinog       Date:  2010-04-16

4.  Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines.

Authors:  Denise K Walters; Roman Muff; Bettina Langsam; Philipp Gruber; Walter Born; Bruno Fuchs
Journal:  Invest New Drugs       Date:  2007-04-26       Impact factor: 3.850

5.  [Effects and side effects of taurolin in experimental peritonitis in the rat].

Authors:  H Hart; J Seifert; W Brendel
Journal:  Langenbecks Arch Chir       Date:  1986

6.  Pharmacokinetics of taurolidine following repeated intravenous infusions measured by HPLC-ESI-MS/MS of the derivatives taurultame and taurinamide in glioblastoma patients.

Authors:  Ruediger Stendel; Louis Scheurer; Kathrin Schlatterer; Urs Stalder; Rolf W Pfirrmann; Ingo Fiss; Hanns Möhler; Laurent Bigler
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

7.  Peritoneal instillation of taurolidine or polihexanide modulates intestinal microcirculation in experimental endotoxemia.

Authors:  Helge Frieling; Kai-Steffen Lauer; Matthias Gründling; Taras Usichenko; Konrad Meissner; Theoni Kanellopoulou; Christian Lehmann; Michael Wendt; Dragan Pavlovic
Journal:  Int J Colorectal Dis       Date:  2006-11-21       Impact factor: 2.796

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.